Link to this page
PMO Precision Medicine Ontology
Last uploaded:
December 16, 2020
Jump to:
Preferred Name | Tazarotene | |
Synonyms |
|
|
ID |
http://www.phoc.org.cn/pmo/class/PMO_00025753 |
|
Database_Cross_Reference |
SNOMEDCT_US:332218002 RXNORM:83947 ATC:D05AX05 NCI:C29487 NCI_NCI-GLOSS:CDR0000559445 MEDCIN:78731 MMSL:5542 SNOMEDCT_US:386935009 MSH:C086827 RCD:m5C.. NCI_FDA:81BDR9Y8PS VANDF:4021045 CHV:0000027756 NCI_DCP:20325 MTHSPL:81BDR9Y8PS NDFRT:N0000148509 NDDF:006668 DRUGBANK:DB00799 SNOMEDCT_US:108906007 USPMG:MTHU001157 NDFRT:N0000006235
|
|
label |
Tazarotene
|
|
MCID |
MC00100512
|
|
PMOID |
PMO:00025753
|
|
prefixIRI |
pmo:PMO_00025753
|
|
prefLabel |
Tazarotene
|
|
Synonym |
Tazarotene (substance) Tazarotenum ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate TAZAROTENE Ethyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate retinoids tazarotene tazarotene (medication) tazarotene [Chemical/Ingredient] tazarotene 3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester Tazarotene (product) 6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl Ester Tazaroteno
|
|
Tree Number |
T6.4.9.7.2.2.2
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping